IP Library Granted Patent US 11,360,096
Granted Patent B2
US 11,360,096 · App. 16/876,934 · Granted Jun 14, 2022

Complex BRET technique for measuring biological interactions

Inventors: Thomas Pack (Durham, NC); Jeffrey Smith (Durham, NC); Sudarshan Rajagopal (Durham, NC); Marc Caron (Durham, NC)
Assignee: Duke University
G01N33/6809C12Q1/66C12Y113/12007G01N2333/90241
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,360,096
App. No.
16/876,934
Granted
Jun 14, 2022
Kind
B2
Abstract

Provided are methods for detecting protein interactions in a sample, the methods comprising: (a) detecting two or more polypeptides that when associated emit a first detectable signal in a first light emission spectrum; (b) contacting the two or more polypeptides with a third polypeptide conjugated to a dipole acceptor moiety that has a second light emission spectrum when excited within a light excitation spectrum, wherein the light excitation spectrum overlaps with the first light emission spectrum; and (c) detecting a second detectable signal emitted in the second light emission spectrum by the dipole acceptor moiety. Also provided are bioluminescent complexes comprising: (a) a first polypeptide conjugated to a dipole acceptor moiety, wherein the emits a first detectable signal in a first light emission spectrum.

Claims (11)

1. A method for detecting protein interactions in a sample, the method comprising:

(a) detecting a first polypeptide and a second polypeptide that when associated emit a first detectable signal in a first light emission spectrum, wherein the first polypeptide is conjugated to a first non-luminescent element and the second polypeptide is conjugated to a second non-luminescent element, wherein the first and second non-luminescent elements form a complex that emits the first detectable signal;

(b) contacting the first polypeptide and the second polypeptide with a third polypeptide conjugated to a dipole acceptor moiety that has a second light emission spectrum when excited within a light excitation spectrum, wherein the light excitation spectrum overlaps with the first light emission spectrum, wherein the contacting places the first polypeptide and the second polypeptide in a proximity sufficient to allow resonance energy transfer from the first and the second polypeptides to the dipole acceptor moiety, thereby exciting the dipole acceptor moiety to emit a second detectable signal;

(c) detecting the second detectable signal emitted in the second light emission spectrum by the dipole acceptor moiety and

(d) determining (i) an increase in a ratio of the second detectable signal:the first detectable signal after the contact between the first polypeptide, the second polypeptide, and the third polypeptide, as compared to a ratio of the second detectable signal: the first detectable signal before the contact between the first polypeptide, the second polypeptide, and the third polypeptide, or (ii) an increase in the second detectable signal following association between the first polypeptide, the second polypeptide and the third polypeptide,

wherein the increase in (i) or (ii) indicates that the first polypeptide, the second polypeptide and the third polypeptide interact to form a complex.

2. The method of claim 1 , wherein the dipole acceptor moiety comprises a fluorescent moiety, a dye, an arsenical protein label, a dye-protein conjugate pair, or a quantum dot.

3. The method of claim 1 , wherein the dipole acceptor moiety comprises a fluorescent moiety.

4. The method of claim 3 , wherein the second light emission spectrum is within a range of from about 445 nm to about 700 nm.

5. The method of claim 1 , wherein the first non-luminescent element and the second non-luminescent element each independently comprise a portion of a luciferase enzyme.

6. The method of claim 1 , wherein the sample comprises a cell, and the contacting is performed by molecular interactions in the cell.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 2, 2023
From: DUKE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065091/0413 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2020
From: PACK, THOMAS; SMITH, JEFFREY; RAJAGOPAL, SUDARSHAN; CARON, MARC
To: DUKE UNIVERSITY
Reel/Frame 054696/0495 →
Continuity (2)
Provisional Application 62848825 · May 16, 2019
Related Publication 20200363424A1 · Nov 19, 2020